Fanny Elahi

Fanny Elahi, a physician-scientist and Associate Professor at the Icahn School of Medicine, dives into the FDA's decision to remove strict warnings on hormone replacement therapies. She highlights the implications for women's health as more women may be encouraged to consider these treatments during menopause. Elahi explains the flaws in previous studies around HRT risks, the importance of personalized discussions with healthcare providers, and how advancements in precision medicine are changing perceptions and acceptance of these therapies.